Aryl hydrocarbon receptor nuclear translocator
AltitudeomicsDB
Protein Official symbol |
ARNT |
Aliases |
ARNT BHLHE2 |
Chromosomal Location |
1 |
Length |
789 |
Uniprot ID |
P27540 |
EC number |
None |
Protein family Information(Pfam) |
PF00010;PF00989; |
PDB id |
1D7G;1X0O;2A24;2ARN;2B02;2HV1;2K7S;3F1N;3F1O;3F1P;3H7W;3H82;4EQ1;4GHI;4GS9;4H6J;4LPZ;4PKY;4XT2;5TBM;5UFP;5V0L;6CZW;6D09;6D0B;6D0C; |
InterPro ID |
IPR011598;IPR036638;IPR001067;IPR001610;IPR000014;IPR035965;IPR013767; |
dbSNP |
rs2229175 rs1805133 rs10305741 rs2275237 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
CYP1A1 |
AHR |
0.997 |
AKT1 |
NOS3 |
0.996 |
VEGFA |
HIF1A |
0.994 |
VEGFA |
NOS3 |
0.993 |
CREB1 |
CREBBP |
0.991 |
JUN |
COPS5 |
0.99 |
AKT1 |
CREB1 |
0.99 |
CREB1 |
JUN |
0.987 |
CREB1 |
EP300 |
0.985 |
CYP1A1 |
ARNT |
0.985 |
AKT1 |
CDKN1A |
0.984 |
HIF1A |
EPO |
0.984 |
EP300 |
CREBBP |
0.984 |
HIF1A |
CA9 |
0.983 |
AKT1 |
HIF1A |
0.982 |
EP300 |
SIRT1 |
0.98 |
AKT1 |
EDN1 |
0.98 |
VEGFA |
JUN |
0.979 |
CYP1A1 |
AHRR |
0.978 |
VEGFA |
ARNT |
0.977 |
JUN |
SMAD3 |
0.975 |
VEGFA |
EPAS1 |
0.974 |
CDKN1A |
JUN |
0.974 |
SMAD3 |
EP300 |
0.973 |
EPAS1 |
EPO |
0.969 |
CA9 |
EPAS1 |
0.969 |
HIF1A |
NOS3 |
0.969 |
CDKN1A |
SMAD3 |
0.969 |
CITED2 |
CREBBP |
0.968 |
LDHA |
HIF1A |
0.968 |
NCOA1 |
EP300 |
0.966 |
NCOA1 |
CREBBP |
0.966 |
JUN |
EP300 |
0.965 |
CDKN1A |
SP1 |
0.965 |
JUN |
SMAD4 |
0.962 |
CREB1 |
EDN1 |
0.962 |
AKT1 |
EP300 |
0.96 |
HIF1A |
EP300 |
0.96 |
CITED2 |
EP300 |
0.96 |
AKT1 |
ARNT |
0.96 |
CDKN1A |
SMAD4 |
0.958 |
JUN |
SP1 |
0.957 |
JUN |
CREBBP |
0.957 |
EP300 |
HDAC7 |
0.956 |
ARNT |
EPO |
0.956 |
EDN1 |
JUN |
0.955 |
SMAD4 |
EP300 |
0.955 |
HIF1A |
JUN |
0.954 |
VEGFA |
CREB1 |
0.954 |
HIF1A |
COPS5 |
0.953 |
JUN |
NOS3 |
0.952 |
CDKN1A |
EP300 |
0.952 |
SP1 |
EP300 |
0.951 |
VEGFA |
EP300 |
0.951 |
AKT1 |
CREBBP |
0.951 |
VEGFA |
AKT1 |
0.951 |
ARNT |
EP300 |
0.951 |
LDHA |
ARNT |
0.946 |
CREB1 |
NOS3 |
0.945 |
HIF1A |
EDN1 |
0.945 |
HIF1A |
CREBBP |
0.945 |
SMAD3 |
CREBBP |
0.945 |
CA9 |
HIF3A |
0.944 |
SMAD4 |
CREBBP |
0.944 |
HIF1A |
CREB1 |
0.943 |
CITED2 |
HIF1A |
0.943 |
CA9 |
ARNT |
0.943 |
ARNT |
AHR |
0.943 |
EDN1 |
NOS3 |
0.941 |
HIF1A |
ARNT |
0.94 |
EP300 |
EPO |
0.939 |
SMAD3 |
SP1 |
0.939 |
CREB1 |
CDKN1A |
0.938 |
HIF1A |
CDKN1A |
0.937 |
CREBBP |
HDAC7 |
0.937 |
ARNT |
CREBBP |
0.936 |
EPAS1 |
SIRT1 |
0.936 |
ARNT |
EPAS1 |
0.936 |
JUN |
EPO |
0.935 |
EPAS1 |
EP300 |
0.934 |
SMAD4 |
SP1 |
0.933 |
HIF1A |
SMAD4 |
0.933 |
HIF1A |
SMAD3 |
0.932 |
HIF1A |
SP1 |
0.932 |
CA9 |
EP300 |
0.93 |
VEGFA |
CREBBP |
0.93 |
CREB1 |
EPO |
0.93 |
CREB1 |
ARNT |
0.929 |
VEGFA |
HIF3A |
0.929 |
EDN1 |
EP300 |
0.928 |
CITED2 |
EPAS1 |
0.928 |
CREBBP |
EPO |
0.928 |
LDHA |
EP300 |
0.927 |
HIF3A |
EPO |
0.926 |
HIF3A |
ARNT |
0.926 |
ARNT |
SP1 |
0.926 |
NOS3 |
EP300 |
0.926 |
ARNT |
AHRR |
0.925 |
COPS5 |
EP300 |
0.924 |
NCOA1 |
CYP1A1 |
0.923 |
JUN |
ARNT |
0.923 |
HIF1A |
HDAC7 |
0.922 |
LDHA |
CREB1 |
0.921 |
JUN |
HDAC7 |
0.919 |
ARNT |
NOS3 |
0.919 |
CDKN1A |
COPS5 |
0.919 |
NCOA1 |
SMAD3 |
0.919 |
EPAS1 |
CREBBP |
0.919 |
COPS5 |
EPO |
0.919 |
LDHA |
JUN |
0.918 |
VEGFA |
COPS5 |
0.918 |
ARNT |
COPS5 |
0.918 |
ARNT |
SIRT1 |
0.918 |
VEGFA |
EPO |
0.918 |
EDN1 |
ARNT |
0.917 |
HEY2 |
ARNT |
0.917 |
HIF1A |
HEY2 |
0.916 |
NCOA1 |
SP1 |
0.916 |
SMAD4 |
SMAD3 |
0.916 |
HIF3A |
EP300 |
0.915 |
CA9 |
CREBBP |
0.914 |
SMAD4 |
EPAS1 |
0.913 |
LDHA |
COPS5 |
0.913 |
HIF1A |
HIGD1A |
0.913 |
CITED2 |
HIF3A |
0.913 |
CITED2 |
NCOA1 |
0.912 |
HEY2 |
EP300 |
0.911 |
AKT1 |
JUN |
0.91 |
NCOA1 |
SMAD4 |
0.91 |
CITED2 |
ARNT |
0.91 |
HIF1A |
ASPH |
0.91 |
CREB1 |
COPS5 |
0.908 |
HIF1A |
NCOA1 |
0.908 |
EDN1 |
COPS5 |
0.908 |
HIF3A |
EPAS1 |
0.908 |
CDKN1A |
ARNT |
0.908 |
HIGD1A |
EPAS1 |
0.907 |
NCOA1 |
ARNT |
0.907 |
ASPH |
JUN |
0.907 |
HIF3A |
CREBBP |
0.907 |
HIF1A |
EPAS1 |
0.907 |
ARNT |
SMAD3 |
0.907 |
ARNT |
APEX1 |
0.906 |
CYP1A1 |
CREBBP |
0.906 |
ASPH |
EP300 |
0.906 |
ASPH |
COPS5 |
0.906 |
AKT1 |
SIRT1 |
0.906 |
HIF1A |
HIF3A |
0.906 |
CREB1 |
ASPH |
0.905 |
EPAS1 |
APEX1 |
0.903 |
CITED2 |
HDAC7 |
0.902 |
ARNT |
SMAD4 |
0.902 |
COPS5 |
NOS3 |
0.902 |
HIGD1A |
ARNT |
0.902 |
ASPH |
ARNT |
0.901 |
ARNT |
HDAC7 |
0.9 |
HIGD1A |
HIF3A |
0.9 |
HEY2 |
CREBBP |
0.9 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
1543 (CYP1A1) |
207 (AKT1) |
7422 (VEGFA) |
1385 (CREB1) |
3725 (JUN) |
3091 (HIF1A) |
2033 (EP300) |
1026 (CDKN1A) |
4088 (SMAD3) |
2034 (EPAS1) |
768 (CA9) |
10370 (CITED2) |
3939 (LDHA) |
8648 (NCOA1) |
405 (ARNT) |
1906 (EDN1) |
4089 (SMAD4) |
6667 (SP1) |
1387 (CREBBP) |
64344 (HIF3A) |
4846 (NOS3) |
10987 (COPS5) |
23493 (HEY2) |
444 (ASPH) |
196 (AHR) |
2056 (EPO) |
23411 (SIRT1) |
57491 (AHRR) |
51564 (HDAC7) |
328 (APEX1) |
1543 (CYP1A1)
|
1.00
|
0.47
|
0.55
|
0.38
|
0.42
|
0.53
|
0.44
|
0.41
|
0.46
|
0.49
|
0.48
|
0.47
|
0.58
|
0.49
|
0.44
|
0.51
|
0.40
|
0.44
|
0.45
|
0.21
|
0.56
|
0.41
|
0.37
|
0.43
|
0.47
|
0.47
|
0.54
|
0.44
|
0.57
|
0.43
|
207 (AKT1)
|
0.47
|
1.00
|
0.58
|
0.44
|
0.50
|
0.54
|
0.47
|
0.63
|
0.50
|
0.50
|
0.46
|
0.48
|
0.47
|
0.50
|
0.48
|
0.50
|
0.47
|
0.48
|
0.47
|
0.21
|
0.48
|
0.41
|
0.41
|
0.45
|
0.50
|
0.50
|
0.55
|
0.45
|
0.59
|
0.36
|
7422 (VEGFA)
|
0.55
|
0.58
|
1.00
|
0.53
|
0.56
|
0.62
|
0.48
|
0.54
|
0.57
|
0.63
|
0.60
|
0.59
|
0.61
|
0.59
|
0.61
|
0.65
|
0.57
|
0.55
|
0.53
|
0.28
|
0.52
|
0.53
|
0.50
|
0.59
|
0.60
|
0.66
|
0.58
|
0.61
|
0.62
|
0.41
|
1385 (CREB1)
|
0.38
|
0.44
|
0.53
|
1.00
|
0.89
|
0.80
|
0.54
|
0.40
|
0.81
|
0.74
|
0.41
|
0.71
|
0.42
|
0.72
|
0.78
|
0.46
|
0.84
|
0.82
|
0.72
|
1.00
|
0.38
|
0.44
|
0.85
|
0.42
|
0.76
|
0.43
|
0.62
|
0.67
|
0.50
|
0.41
|
3725 (JUN)
|
0.42
|
0.50
|
0.56
|
0.89
|
1.00
|
0.82
|
0.60
|
0.48
|
0.85
|
0.78
|
0.44
|
0.66
|
0.45
|
0.69
|
0.83
|
0.48
|
0.84
|
0.85
|
0.74
|
1.00
|
0.45
|
0.52
|
0.81
|
0.45
|
0.82
|
0.48
|
0.60
|
0.62
|
0.51
|
0.51
|
3091 (HIF1A)
|
0.53
|
0.54
|
0.62
|
0.80
|
0.82
|
1.00
|
0.56
|
0.59
|
0.79
|
0.89
|
0.58
|
0.74
|
0.59
|
0.78
|
0.86
|
0.60
|
0.74
|
0.81
|
0.70
|
1.00
|
0.50
|
0.53
|
0.80
|
0.56
|
0.83
|
0.59
|
0.69
|
0.78
|
0.66
|
0.46
|
2033 (EP300)
|
0.44
|
0.47
|
0.48
|
0.54
|
0.60
|
0.56
|
1.00
|
0.43
|
0.61
|
0.55
|
0.42
|
0.53
|
0.42
|
0.58
|
0.52
|
0.44
|
0.56
|
0.60
|
0.79
|
0.21
|
0.45
|
0.47
|
0.55
|
0.41
|
0.56
|
0.42
|
0.55
|
0.41
|
0.54
|
0.51
|
1026 (CDKN1A)
|
0.41
|
0.63
|
0.54
|
0.40
|
0.48
|
0.59
|
0.43
|
1.00
|
0.50
|
0.49
|
0.44
|
0.51
|
0.46
|
0.50
|
0.44
|
0.51
|
0.41
|
0.44
|
0.46
|
0.21
|
0.38
|
0.37
|
0.38
|
0.43
|
0.47
|
0.63
|
0.51
|
0.44
|
0.62
|
0.30
|
4088 (SMAD3)
|
0.46
|
0.50
|
0.57
|
0.81
|
0.85
|
0.79
|
0.61
|
0.50
|
1.00
|
0.72
|
0.48
|
0.63
|
0.49
|
0.68
|
0.77
|
0.50
|
0.83
|
0.81
|
0.71
|
1.00
|
0.49
|
0.52
|
0.78
|
0.50
|
0.77
|
0.50
|
0.63
|
0.60
|
0.56
|
0.53
|
2034 (EPAS1)
|
0.49
|
0.50
|
0.63
|
0.74
|
0.78
|
0.89
|
0.55
|
0.49
|
0.72
|
1.00
|
0.59
|
0.68
|
0.59
|
0.67
|
0.89
|
0.62
|
0.74
|
0.82
|
0.67
|
1.00
|
0.49
|
0.51
|
0.80
|
0.54
|
0.84
|
0.59
|
0.59
|
0.77
|
0.64
|
0.45
|
768 (CA9)
|
0.48
|
0.46
|
0.60
|
0.41
|
0.44
|
0.58
|
0.42
|
0.44
|
0.48
|
0.59
|
1.00
|
0.55
|
0.61
|
0.56
|
0.49
|
0.65
|
0.43
|
0.47
|
0.45
|
0.21
|
0.41
|
0.40
|
0.40
|
0.50
|
0.51
|
0.60
|
0.53
|
0.59
|
0.65
|
0.31
|
10370 (CITED2)
|
0.47
|
0.48
|
0.59
|
0.71
|
0.66
|
0.74
|
0.53
|
0.51
|
0.63
|
0.68
|
0.55
|
1.00
|
0.56
|
0.77
|
0.64
|
0.59
|
0.63
|
0.59
|
0.69
|
0.82
|
0.42
|
0.60
|
0.68
|
0.52
|
0.61
|
0.56
|
0.64
|
0.67
|
0.59
|
0.45
|
3939 (LDHA)
|
0.58
|
0.47
|
0.61
|
0.42
|
0.45
|
0.59
|
0.42
|
0.46
|
0.49
|
0.59
|
0.61
|
0.56
|
1.00
|
0.56
|
0.50
|
0.65
|
0.44
|
0.48
|
0.46
|
0.21
|
0.46
|
0.42
|
0.41
|
0.52
|
0.51
|
0.61
|
0.53
|
0.61
|
0.65
|
0.32
|
8648 (NCOA1)
|
0.49
|
0.50
|
0.59
|
0.72
|
0.69
|
0.78
|
0.58
|
0.50
|
0.68
|
0.67
|
0.56
|
0.77
|
0.56
|
1.00
|
0.68
|
0.59
|
0.63
|
0.61
|
0.64
|
1.00
|
0.45
|
0.61
|
0.67
|
0.53
|
0.62
|
0.57
|
0.66
|
0.68
|
0.60
|
0.43
|
405 (ARNT)
|
0.44
|
0.48
|
0.61
|
0.78
|
0.83
|
0.86
|
0.52
|
0.44
|
0.77
|
0.89
|
0.49
|
0.64
|
0.50
|
0.68
|
1.00
|
0.54
|
0.79
|
0.86
|
0.68
|
1.00
|
0.45
|
0.46
|
0.83
|
0.48
|
0.91
|
0.51
|
0.57
|
0.71
|
0.56
|
0.43
|
1906 (EDN1)
|
0.51
|
0.50
|
0.65
|
0.46
|
0.48
|
0.60
|
0.44
|
0.51
|
0.50
|
0.62
|
0.65
|
0.59
|
0.65
|
0.59
|
0.54
|
1.00
|
0.47
|
0.50
|
0.49
|
0.21
|
0.44
|
0.48
|
0.45
|
0.57
|
0.54
|
0.71
|
0.54
|
0.65
|
0.66
|
0.32
|
4089 (SMAD4)
|
0.40
|
0.47
|
0.57
|
0.84
|
0.84
|
0.74
|
0.56
|
0.41
|
0.83
|
0.74
|
0.43
|
0.63
|
0.44
|
0.63
|
0.79
|
0.47
|
1.00
|
0.85
|
0.69
|
1.00
|
0.44
|
0.48
|
0.80
|
0.43
|
0.78
|
0.45
|
0.58
|
0.58
|
0.48
|
0.49
|
6667 (SP1)
|
0.44
|
0.48
|
0.55
|
0.82
|
0.85
|
0.81
|
0.60
|
0.44
|
0.81
|
0.82
|
0.47
|
0.59
|
0.48
|
0.61
|
0.86
|
0.50
|
0.85
|
1.00
|
0.74
|
1.00
|
0.47
|
0.47
|
0.86
|
0.47
|
0.85
|
0.48
|
0.61
|
0.62
|
0.55
|
0.48
|
1387 (CREBBP)
|
0.45
|
0.47
|
0.53
|
0.72
|
0.74
|
0.70
|
0.79
|
0.46
|
0.71
|
0.67
|
0.45
|
0.69
|
0.46
|
0.64
|
0.68
|
0.49
|
0.69
|
0.74
|
1.00
|
0.82
|
0.44
|
0.50
|
0.75
|
0.45
|
0.69
|
0.47
|
0.59
|
0.55
|
0.56
|
0.49
|
64344 (HIF3A)
|
0.21
|
0.21
|
0.28
|
1.00
|
1.00
|
1.00
|
0.21
|
0.21
|
1.00
|
1.00
|
0.21
|
0.82
|
0.21
|
1.00
|
1.00
|
0.21
|
1.00
|
1.00
|
0.82
|
1.00
|
0.21
|
0.21
|
1.00
|
0.28
|
1.00
|
0.21
|
0.65
|
1.00
|
0.21
|
0.21
|
4846 (NOS3)
|
0.56
|
0.48
|
0.52
|
0.38
|
0.45
|
0.50
|
0.45
|
0.38
|
0.49
|
0.49
|
0.41
|
0.42
|
0.46
|
0.45
|
0.45
|
0.44
|
0.44
|
0.47
|
0.44
|
0.21
|
1.00
|
0.40
|
0.40
|
0.44
|
0.48
|
0.41
|
0.57
|
0.38
|
0.48
|
0.47
|
10987 (COPS5)
|
0.41
|
0.41
|
0.53
|
0.44
|
0.52
|
0.53
|
0.47
|
0.37
|
0.52
|
0.51
|
0.40
|
0.60
|
0.42
|
0.61
|
0.46
|
0.48
|
0.48
|
0.47
|
0.50
|
0.21
|
0.40
|
1.00
|
0.44
|
0.40
|
0.49
|
0.43
|
0.57
|
0.39
|
0.51
|
0.47
|
23493 (HEY2)
|
0.37
|
0.41
|
0.50
|
0.85
|
0.81
|
0.80
|
0.55
|
0.38
|
0.78
|
0.80
|
0.40
|
0.68
|
0.41
|
0.67
|
0.83
|
0.45
|
0.80
|
0.86
|
0.75
|
1.00
|
0.40
|
0.44
|
1.00
|
0.41
|
0.79
|
0.42
|
0.62
|
0.64
|
0.49
|
0.46
|
444 (ASPH)
|
0.43
|
0.45
|
0.59
|
0.42
|
0.45
|
0.56
|
0.41
|
0.43
|
0.50
|
0.54
|
0.50
|
0.52
|
0.52
|
0.53
|
0.48
|
0.57
|
0.43
|
0.47
|
0.45
|
0.28
|
0.44
|
0.40
|
0.41
|
1.00
|
0.50
|
0.53
|
0.51
|
0.51
|
0.57
|
0.34
|
196 (AHR)
|
0.47
|
0.50
|
0.60
|
0.76
|
0.82
|
0.83
|
0.56
|
0.47
|
0.77
|
0.84
|
0.51
|
0.61
|
0.51
|
0.62
|
0.91
|
0.54
|
0.78
|
0.85
|
0.69
|
1.00
|
0.48
|
0.49
|
0.79
|
0.50
|
1.00
|
0.52
|
0.57
|
0.65
|
0.55
|
0.48
|
2056 (EPO)
|
0.47
|
0.50
|
0.66
|
0.43
|
0.48
|
0.59
|
0.42
|
0.63
|
0.50
|
0.59
|
0.60
|
0.56
|
0.61
|
0.57
|
0.51
|
0.71
|
0.45
|
0.48
|
0.47
|
0.21
|
0.41
|
0.43
|
0.42
|
0.53
|
0.52
|
1.00
|
0.53
|
0.61
|
0.63
|
0.30
|
23411 (SIRT1)
|
0.54
|
0.55
|
0.58
|
0.62
|
0.60
|
0.69
|
0.55
|
0.51
|
0.63
|
0.59
|
0.53
|
0.64
|
0.53
|
0.66
|
0.57
|
0.54
|
0.58
|
0.61
|
0.59
|
0.65
|
0.57
|
0.57
|
0.62
|
0.51
|
0.57
|
0.53
|
1.00
|
0.56
|
0.60
|
0.52
|
57491 (AHRR)
|
0.44
|
0.45
|
0.61
|
0.67
|
0.62
|
0.78
|
0.41
|
0.44
|
0.60
|
0.77
|
0.59
|
0.67
|
0.61
|
0.68
|
0.71
|
0.65
|
0.58
|
0.62
|
0.55
|
1.00
|
0.38
|
0.39
|
0.64
|
0.51
|
0.65
|
0.61
|
0.56
|
1.00
|
0.64
|
0.27
|
51564 (HDAC7)
|
0.57
|
0.59
|
0.62
|
0.50
|
0.51
|
0.66
|
0.54
|
0.62
|
0.56
|
0.64
|
0.65
|
0.59
|
0.65
|
0.60
|
0.56
|
0.66
|
0.48
|
0.55
|
0.56
|
0.21
|
0.48
|
0.51
|
0.49
|
0.57
|
0.55
|
0.63
|
0.60
|
0.64
|
1.00
|
0.38
|
328 (APEX1)
|
0.43
|
0.36
|
0.41
|
0.41
|
0.51
|
0.46
|
0.51
|
0.30
|
0.53
|
0.45
|
0.31
|
0.45
|
0.32
|
0.43
|
0.43
|
0.32
|
0.49
|
0.48
|
0.49
|
0.21
|
0.47
|
0.47
|
0.46
|
0.34
|
0.48
|
0.30
|
0.52
|
0.27
|
0.38
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
ARNT |
Mice |
Blood |
8% Oxygen |
7600 m |
24 hours |
upregulated |
14.8 |
RT-qPCR |
Western US |
C57BL/6 mice |
5.2 |
7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) |
24183776 |
ARNT |
Mice |
Blood |
8% Oxygen |
7600 m |
24 hours |
upregulated |
24.1 |
RT-qPCR |
Western US |
C57BL/6 mice |
5.2 |
7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) |
24183776 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
405 |
GO:0001666 |
response to hypoxia |
GOTERM_BP_DIRECT |
405 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway |
GOTERM_BP_DIRECT |
405 |
GO:0046886 |
positive regulation of hormone biosynthetic process |
GOTERM_BP_DIRECT |
405 |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
405 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
405 |
GO:0005654 |
nucleoplasm |
GOTERM_CC_DIRECT |
405 |
GO:0030522 |
intracellular receptor signaling pathway |
GOTERM_BP_DIRECT |
405 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
405 |
GO:0035326 |
glucocorticoid receptor binding |
GOTERM_MF_DIRECT |
405 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
405 |
GO:0003713 |
transcription coactivator activity |
GOTERM_MF_DIRECT |
405 |
GO:0017162 |
DEAD/H-box RNA helicase binding |
GOTERM_MF_DIRECT |
405 |
GO:0010575 |
positive regulation of vascular endothelial growth factor production |
GOTERM_BP_DIRECT |
405 |
GO:0005667 |
transcription factor complex |
GOTERM_CC_DIRECT |
405 |
GO:0006351 |
transcription |
GOTERM_BP_DIRECT |
405 |
GO:0043565 |
sequence-specific DNA binding |
GOTERM_MF_DIRECT |
405 |
GO:0001892 |
embryonic placenta development |
GOTERM_BP_DIRECT |
405 |
GO:0030154 |
cell differentiation |
GOTERM_BP_DIRECT |
405 |
GO:0033235 |
positive regulation of protein sumoylation |
GOTERM_BP_DIRECT |
405 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
GOTERM_BP_DIRECT |
405 |
GO:0090575 |
RNA polymerase II transcription factor complex |
GOTERM_CC_DIRECT |
405 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
GOTERM_BP_DIRECT |
405 |
GO:0045648 |
positive regulation of erythrocyte differentiation |
GOTERM_BP_DIRECT |
405 |
GO:0003705 |
transcription factor activity |
GOTERM_MF_DIRECT |
405 |
GO:0008134 |
transcription factor binding |
GOTERM_MF_DIRECT |
405 |
GO:0001938 |
positive regulation of endothelial cell proliferation |
GOTERM_BP_DIRECT |
405 |
GO:0045821 |
positive regulation of glycolytic process |
GOTERM_BP_DIRECT |
405 |
GO:0045893 |
positive regulation of transcription |
GOTERM_BP_DIRECT |
405 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
405 |
GO:0046982 |
protein heterodimerization activity |
GOTERM_MF_DIRECT |
405 |
GO:0003677 |
DNA binding |
GOTERM_MF_DIRECT |
405 |
GO:0003700 |
transcription factor activity |
GOTERM_MF_DIRECT |
405 |
GO:0004874 |
receptor activity |
GOTERM_MF_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
405 |
hsa04066 |
HIF-1 signaling pathway |
405 |
hsa05200 |
Pathways in cancer |
405 |
hsa05211 |
Renal cell carcinoma |
405 |
hsa05204 |
Chemical carcinogenesis |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
ARNT |
405 |
Abortion, Tubal |
C0000822 |
Pathologic Function |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Colorectal Neoplasms |
C0009404 |
Neoplastic Process |
0.3 |
0.602 |
0.552 |
group |
ARNT |
405 |
Endometriosis |
C0014175 |
Disease or Syndrome |
0.33 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Neoplasms, Experimental |
C0027659 |
Experimental Model of Disease; Neoplastic Process |
0.3 |
0.602 |
0.552 |
group |
ARNT |
405 |
Hepatitis, Toxic |
C0019193 |
Injury or Poisoning |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Childhood Acute Lymphoblastic Leukemia |
C0023452 |
Neoplastic Process |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Endometrioma |
C0269102 |
Neoplastic Process |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Hepatitis, Drug-Induced |
C1262760 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Liver Cirrhosis |
C0023890 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Colorectal Cancer |
C1527249 |
Neoplastic Process |
0.32 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Fibrosis, Liver |
C0239946 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Drug-Induced Acute Liver Injury |
C3658290 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Leukemia, Lymphocytic, Acute, L2 |
C0023453 |
Neoplastic Process |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Chemical and Drug Induced Liver Injury |
C4277682 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Colorectal Carcinoma |
C0009402 |
Neoplastic Process |
0.32 |
0.602 |
0.552 |
disease |
ARNT |
405 |
melanoma |
C0025202 |
Neoplastic Process |
0.36 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Precursor Cell Lymphoblastic Leukemia Lymphoma |
C1961102 |
Neoplastic Process |
0.31 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Chemically-Induced Liver Toxicity |
C4279912 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
ARNT |
405 |
Spontaneous abortion |
C0000786 |
Pathologic Function |
0.3 |
0.602 |
0.552 |
phenotype |
ARNT |
405 |
Drug-Induced Liver Disease |
C0860207 |
Disease or Syndrome |
0.3 |
0.602 |
0.552 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
ARNT |
405 |
HYDROCORTISONE |
HYDROCORTISONE |
CHEMBL389621 |
None |
ARNT |
405 |
PROTEASOME INHIBITOR |
None |
None |
None |
ARNT |
405 |
TCDD |
None |
None |
None |